openPR Logo
Press release

What's driving the Contraceptive Drugs Market Growth? Prominent Players: Bayer AG, Pfizer Inc., Janssen Global Services, LLC, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Mylan N.V., Allergan Plc, Agile Therapeutics, Piramal Enterprises Ltd.

09-15-2021 07:47 AM CET | Health & Medicine

Press release from: Fortune Business Insights

What's driving the Contraceptive Drugs Market Growth?

Contraceptive Drugs Market Size | 2021 Covid-19 Impact On Healthcare Industry Global Analysis By Size, Trends, Growth, Share, Business, Key Players, Merger, Statistics, Competitive Landscape, And Regional Forecast To 2028 is latest study published by Fortune Business Insights. According to the report, the global contraceptive drugs market is anticipated to rise at 5.8% CAGR and reach a value of US$ 20,200.5 Mn by 2025 from US$ 13,097.7 Mn in 2017. Contraceptive Drugs Market Size, Share and Global Trend By Product Type (Oral, Injectable, Patches), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel & NGOs) and Geography Forecast till 2025

Leading Players operating in the Contraceptive Drugs Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

Bayer AG
Pfizer Inc.
Janssen Global Services, LLC
Teva Pharmaceutical Industries Ltd.
Merck & Co., Inc.
Mylan N.V.
Allergan Plc
Agile Therapeutics
Piramal Enterprises Ltd.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/contraceptive-drugs-market-100063

Global Contraceptive Drugs Market Highlights:

The Contraceptive Drugs Market report offers an in-depth analysis of the Contraceptive Drugs industry and the demand drivers by highlighting information on several aspects of the market. Prudent Markets addresses all these aspects and provides the latest scoop and detailed eye-opening study on all major & emerging business segments. In addition to this, the report sheds light on the industry developments by key players, which are contributing to the expansion of this industry. The development scope, feasibility study, Contraceptive Drugs market concentration, and maturity analysis is elaborated in this report.

Information given in the research report pertains to different technological advancements introduced in recent years, which allows for a meticulous analysis of the industry and offers a more comprehensive understanding to the readers.

Rising Abortion Rates to Create Demand for Contraceptive Drugs

Under the Affordable Care Act (ACA) in the U.S., oral contraceptive pills are given free of cost to women in the U.S. Such regulations favor the growth of the contraceptive drugs market. Increasing government initiatives to reduce infant mortality due to early pregnancies will increase the demand for oral contraceptives.

Regional Analysis:

North America (the USA and Canada)
Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
Latin America (Brazil, Mexico and Rest of Latin America)
Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)
This report focuses on Contraceptive Drugs Global Market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report. This section sheds light on the sales growth of different regional and country-level markets. For the historical and forecast period to 2026, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market.

Government Initiatives to Promote Use of Contraceptive Medicines

Geographically, North America held dominance in the global contraceptive drugs market owing to the presence of leading players in the region. This, accompanied with easy availability of contraceptive drugs, has catapulted North America to the fore of the global market. However, Asia Pacific is most likely to emerge as the fastest growing region.

This is owing to government initiatives adopted across emerging nations of this region. These initiatives are intended at promoting the use of contraceptive medicines as a convenient way of preventing unwanted pregnancy.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/contraceptive-drugs-market-100063

Detailed Table of Content:

1 Market Overview

1.1 Contraceptive Drugs Introduction

1.2 Market Analysis by Type

1.3 Market Analysis by Applications

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2020-2026)

1.4.1.2 Canada Market States and Outlook (2020-2026)

1.4.1.3 Mexico Market States and Outlook (2020-2026)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2020-2026)

1.4.2.2 France Market States and Outlook (2020-2026)

1.4.2.3 UK Market States and Outlook (2020-2026)

1.4.2.4 Russia Market States and Outlook (2020-2026)

1.4.2.5 Italy Market States and Outlook (2020-2026)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2020-2026)

1.4.3.2 Japan Market States and Outlook (2020-2026)

1.4.3.3 Korea Market States and Outlook (2020-2026)

1.4.3.4 India Market States and Outlook (2020-2026)

1.4.3.5 Southeast Asia Market States and Outlook (2020-2026)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2020-2026)

1.4.4.2 Egypt Market States and Outlook (2020-2026)

1.4.4.3 Saudi Arabia Market States and Outlook (2020-2026)

1.4.4.4 South Africa Market States and Outlook (2020-2026)

1.4.4.5 Turkey Market States and Outlook (2020-2026)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

3 Global Contraceptive Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Contraceptive Drugs Sales and Market Share by Manufacturer (2017-2018)

3.2 Global Contraceptive Drugs Revenue and Market Share by Manufacturer (2017-2018)

3.3 Market Concentration Rate

3.3.1 Top 3 Contraceptive Drugs Manufacturer Market Share in 2018

3.3.2 Top 6 Contraceptive Drugs Manufacturer Market Share in 2018

3.4 Market Competition Trend

4 Global Contraceptive Drugs Market Analysis by Regions

4.1 Global Contraceptive Drugs Sales, Revenue and Market Share by Regions

4.1.1 Global Contraceptive Drugs Sales and Market Share by Regions (2020-2028)

4.1.2 Global Contraceptive Drugs Revenue and Market Share by Regions (2020-2028)

4.2 North America Contraceptive Drugs Sales and Growth Rate (2020-2028)

4.3 Europe Contraceptive Drugs Sales and Growth Rate (2020-2028)

4.4 Asia-Pacific Contraceptive Drugs Sales and Growth Rate (2020-2028)

4.5 South America Contraceptive Drugs Sales and Growth Rate (2020-2028)

4.6 Middle East and Africa Contraceptive Drugs Sales and Growth Rate (2020-2028)

5 North America Contraceptive Drugs by Country

5.1 North America Contraceptive Drugs Sales, Revenue and Market Share by Country

5.1.1 North America Contraceptive Drugs Sales and Market Share by Country (2020-2028)

5.1.2 North America Contraceptive Drugs Revenue and Market Share by Country (2020-2028)

5.2 United States Contraceptive Drugs Sales and Growth Rate (2020-2028)

5.3 Canada Contraceptive Drugs Sales and Growth Rate (2020-2028)

5.4 Mexico Contraceptive Drugs Sales and Growth Rate (2020-2028)

8 South America Contraceptive Drugs by Country

8.1 South America Contraceptive Drugs Sales, Revenue and Market Share by Country

8.1.1 South America Contraceptive Drugs Sales and Market Share by Country (2020-2028)

8.1.2 South America Contraceptive Drugs Revenue and Market Share by Country (2020-2028)

8.2 Brazil Contraceptive Drugs Sales and Growth Rate (2020-2028)

TOC Continued….!

Have Any Query? Ask Our Experts:https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/contraceptive-drugs-market-100063

Report Focus:

Extensive product offerings
Customer research services
Robust research methodology
Comprehensive reports
Latest technological developments
Value chain analysis
Potential Contraceptive Drugs Market opportunities
Growth dynamics
Quality assurance
Post-sales support
Regular report updates
Reasons to Purchase this Report:

Comprehensive analysis of the Contraceptive Drugs Market growth drivers, obstacles, opportunities, and other related challenges.
Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
Identifies market restraints and boosters.
Identifies all the possible segments present in the market to aid organizations in strategic business planning.

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What's driving the Contraceptive Drugs Market Growth? Prominent Players: Bayer AG, Pfizer Inc., Janssen Global Services, LLC, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Mylan N.V., Allergan Plc, Agile Therapeutics, Piramal Enterprises Ltd. here

News-ID: 2393281 • Views: 249

More Releases from Fortune Business Insights

Urticaria Treatment Market | 2021 Global Industry Analysis By Covid-19 Impact On …
Global Urticaria Treatment market 2020 industry research report gives Advancement strategies and plans are talked about just as assembling procedures and cost structures are likewise examined. Urticaria Treatment Market Report states import/send out utilization, organic market Figures, cost, value, income and gross edges. This report also studies the global Urticaria Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
Global Intravenous Immunoglobulin Market To Exhibit 6.2% CAGR, Fortune Business …
Fortune Business Insights predicts the Global Intravenous Immunoglobulin Market to reach a value of US$ 15,789.1 Mn from US$ 9,787.6 Mn. The forecast period is set from 2018 and the market is expected to grow at a CAGR of 6.2%. All information related to the market is provided in the report, titled, “Intravenous Immunoglobulin Market Size, Share and Global Trend by Indication (Primary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Guillain-Barré
Patient Monitoring Devices Market | 2021 Global Industry Analysis By Covid-19 Im …
Global Patient Monitoring Devices Market 2020 industry research report gives Advancement strategies and plans are talked about just as assembling procedures and cost structures are likewise examined. Patient Monitoring Devices Market Report states import/send out utilization, organic market Figures, cost, value, income and gross edges. This report also studies the global Patient Monitoring Devices market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales
Dental Impression Trays Market| 2021 Global Industry Analysis By Covid-19 Impact …
Global Dental Impression Trays Market 2020 industry research report gives Advancement strategies and plans are talked about just as assembling procedures and cost structures are likewise examined. Dental Impression Trays Market Report states import/send out utilization, organic market Figures, cost, value, income and gross edges. This report also studies the global Dental Impression Trays market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales

All 5 Releases


More Releases for Contraceptive

Contraceptive Pills
Oral contraceptive pills is a kind of female hormonal anti-conception medication technique that is used for avoiding pregnancy. Contraceptive drugs are used to prevent the unwanted pregnancy by blocking the normal process of ovulations or by altering the process which support the fertilization of egg. The prevalence of women with unmet contraception needs was accounted at 214 million in 2018 by WHO. Further, as indicated by, United Nations,
Intrauterine Contraceptive Devices Market Future Opportunities 2025
Intrauterine contraceptive device (IUD) is a T-shaped, small-sized, birth control device that is inserted into woman’s uterus to prevent pregnancy. These devices are highly effective, economical, and safe birth control devices. IUDs are considered 99% safe in preventing pregnancy. The contraceptive effect of IUDs is attributable to the localized inflammation that occurs after insertion. The inflammatory reaction in the uterus produces substances that are poisonous for sperms. This affects fertilization.
Asia-Pacific Contraceptive Drugs Market Report 2017
The Values marked with XX is confidential data. To know more about CAGR figures fill in your information so that our business development executive can get in touch with you. In this report, the Asia-Pacific Contraceptive Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Request Sample Copy
Oral Contraceptive Pills Market: Regional & Competitive Analysis
According to TMR, the global oral contraceptive pills market is expected to be worth US$22.9 bn by 2023. On the basis of type, the position of combination oral contraceptive pill segment remains undisputed and is estimated to be worth US$18 bn by 2023. The segment is also identified as the fastest growing segment within the market. On the basis of category, the generic oral contraceptive pill segment will lead in
Intrauterine Contraceptive Devices (IUD) Market | Size | Analysis
Intrauterine devices (IUDs) are contraceptive medical implants used to avoid pregnancies for a long time period. IUD’S are also known as long-acting reversible contraceptive devices. An IUD is a T-shaped device which is made of flexible plastic along with a copper wire wrapped around its stem and is a reliable and safe method of sterilization for women. It is injected into the uterus, and their primary aim is to inhibit
U.S. Contraceptives Drugs And Devices Market, By Product Type (Contraceptive Dru …
Contraceptive Drugs and Devices – Choice to Conceive, Not Concede As per stats released by Guttmacher Institute, there were around 61 million women in the U.S. in the childbearing age group (15-44 years) in 2014. Around 10% of these women do not use any contraceptive method. The UN estimates (2015) that unmet need for contraceptives in the North America region is 7%. Thus, there still is an untapped market in the